KALA BIO, Inc. Quarterly Operating Lease, Payments in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
KALA BIO, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2017 to Q2 2024.
  • KALA BIO, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $142K, a 4633% increase year-over-year.
  • KALA BIO, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $475K, a 31.6% increase year-over-year.
  • KALA BIO, Inc. annual Operating Lease, Payments for 2023 was $203K, a 84.6% decline from 2022.
  • KALA BIO, Inc. annual Operating Lease, Payments for 2022 was $1.32M, a 82.1% decline from 2021.
  • KALA BIO, Inc. annual Operating Lease, Payments for 2021 was $7.35M, a 22.9% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $475K $142K +$139K +4633% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $336K $143K +$133K +1330% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $203K $142K +$132K +1320% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $71K $48K -$290K -85.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $361K $3K -$248K -98.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $609K $10K -$709K -98.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.32M $10K -$2.42M -99.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $3.74M $338K -$1.34M -79.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $5.08M $251K -$1.41M -84.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $6.49M $719K -$865K -54.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $7.35M $2.43M +$1.01M +71.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-03
Q3 2021 $6.34M $1.68M +$244K +17.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.09M $1.66M -$27K -1.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6.12M $1.58M +$140K +9.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $5.98M $1.42M -$928K -39.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $6.91M $1.43M -$12K -0.83% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $6.92M $1.69M +$775K +85.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $6.15M $1.44M +$701K +94.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $5.45M $2.35M +$1.67M +245% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.78M $1.44M +$1.34M +1301% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.44M $911K +$808K +784% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.63M $743K +$641K +628% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $988K $680K +$581K +587% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 $407K $103K +$3K +3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $404K $103K +$3K +3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $401K $102K +$5K +5.16% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $396K $99K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $100K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $100K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $97K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.